# Akathisia in Post Operative Outpatients Surgery

> **NCT01942343** · PHASE3 · COMPLETED · sponsor: **University Hospital, Strasbourg, France** · enrollment: 300 (actual)

## Conditions studied

- Akathisia

## Interventions

- **DRUG:** Droperidol 1,25 mg administration, Droperidol 0,625 mg administration, Odansetron 4 mg administration

## Key facts

- **NCT ID:** NCT01942343
- **Lead sponsor:** University Hospital, Strasbourg, France
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2015-10
- **Final completion:** 2015-10
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2026-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01942343

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01942343, "Akathisia in Post Operative Outpatients Surgery". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01942343. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*